| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | SEARCH RESULT |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Immunology |
Departments of 1 Gynecologic Oncology, 2 Breast Medical Oncology, and 3 Immunology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; 4 Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland; and 5 Infectious Disease Research Institute, Seattle, Washington
Requests for reprints: Constantin G. Ioannides, Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Unit 440, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-2849; Fax: 713-792-3575; E-mail: cioannid{at}mdanderson.org .
CD8+ cells expressing high numbers of TCR per cell
(TCRhi) are considered important mediators of antitumor
effects. To understand the relationship between TCR density and
antigen affinity for TCR in the outcome of stimulation with antigen
and differentiation of CTL recognizing tumor antigen, we analyzed
perforin induction in ovarian tumor-associated lymphocytes in
response to the smallest possible changes in the atomic forces of
interaction between antigen and TCR. Stimulating undifferentiated,
apoptosis-resistant CD8+ cells expressing high levels of
E75-TCR (TCRhi) with variants of the CTL epitope E75,
HER-2 (369-377), induced their stepwise differentiation, first to
IFN-
+
Perf– and to TCRhi IFN-
+ Perf+
cells. Blocking caspase-9 activation at antigen stimulation also
enhanced the generation of TCRhi Perfhi cells,
demonstrating that TCR density dictated the pathway of death
activated by stimulation with the same agonist. Expansion and
differentiation of TCRhi Perf+ CTL required an
agonist of optimal CH2 side chain length, which in this
study was equal to two CH2 groups appended to E75 at the
Gly4 position. Side chains one CH2 shorter or
longer than optimal were either less stimulatory or induced
death of TCRhi Perf+ cells. Differentiation of
TCRhi CD8+ cells can be finely tuned by
synthetic amino acids in the peptide, whose side chains induce small
increments in the affinity of the antigen for TCR below the affinity
which induce apoptosis.
Key Words: CTL • perforin • TCR • synthetic amino acids • HER-2
This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)
![]() |
N. Tsuda, D. Z. Chang, T. Mine, C. Efferson, A. Garcia-Sastre, X. Wang, S. Ferrone, and C. G. Ioannides Taxol Increases the Amount and T Cell Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells Cancer Res., September 1, 2007; 67(17): 8378 - 8387. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | SEARCH RESULT |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |